Meehyein Kim Selected Research

Infections

11/2023	Discovery of antiviral SARS-CoV-2 main protease inhibitors by structure-guided hit-to-lead optimization of carmofur.
1/2023	Evaluation of Antiviral Activity of Gemcitabine Derivatives against Influenza Virus and Severe Acute Respiratory Syndrome Coronavirus 2.
5/2022	The efficacy of a 2,4-diaminoquinazoline compound as an intranasal vaccine adjuvant to protect against influenza A virus infection in vivo.
12/2021	Antiviral activity of lambda-carrageenan against influenza viruses and severe acute respiratory syndrome coronavirus 2.
1/2021	Determination of the vRNA and cRNA promoter activity by M segment-specific non-coding nucleotides of influenza A virus.
10/2020	SAR study of bisamides as cyclophilin a inhibitors for the development of host-targeting therapy for hepatitis C virus infection.
9/2020	TRIM Proteins and Their Roles in the Influenza Virus Life Cycle.
12/2018	Salinomycin Inhibits Influenza Virus Infection by Disrupting Endosomal Acidification and Viral Matrix Protein 2 Function.
1/2018	Saracatinib Inhibits Middle East Respiratory Syndrome-Coronavirus Replication In Vitro.
12/2017	Comparison of anti-influenza virus activity and pharmacokinetics of oseltamivir free base and oseltamivir phosphate.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Meehyein Kim Research Topics

Disease

15	Infections 11/2023 - 02/2012
12	Human Influenza (Influenza) 12/2021 - 02/2012
10	Virus Diseases (Viral Diseases) 05/2024 - 12/2018
6	Neoplasms (Cancer) 06/2019 - 06/2007
4	COVID-19 05/2024 - 02/2021
2	Body Weight (Weight, Body) 05/2022 - 12/2021
1	Chronic Hepatitis C 10/2020
1	Flavivirus Infections 01/2019
1	Severe Acute Respiratory Syndrome 01/2018
1	Enterovirus Infections 12/2015
1	Hepatocellular Carcinoma (Hepatoma) 12/2006
1	Chronic Hepatitis (Chronic Active Hepatitis) 08/2006

Drug/Important Bio-Agent (IBA)

13	Antiviral Agents (Antivirals)IBA 12/2021 - 02/2012
5	RNA (Ribonucleic Acid)IBA 06/2019 - 12/2006
4	Gemcitabine FDA Link 01/2023 - 12/2015
4	Viral ProteinsIBA 12/2021 - 12/2006
3	Viral RNAIBA 01/2023 - 11/2013
3	VaccinesIBA 05/2022 - 12/2017
3	Proteins (Proteins, Gene)FDA Link 07/2019 - 10/2016
2	Serine Proteases (Serine Protease)IBA 05/2024 - 01/2022
2	Peptide Hydrolases (Proteases)FDA Link 11/2023 - 10/2020
2	Cyclophilin AIBA 10/2020 - 12/2015
2	Hemagglutinins (Hemagglutinin)IBA 01/2020 - 07/2019
2	LigandsIBA 11/2018 - 01/2018
2	Small Interfering RNA (siRNA)IBA 06/2007 - 12/2006
1	nafamostatIBA 05/2024
1	Diphenoxylate FDA LinkGeneric 05/2024
1	PolyproteinsIBA 11/2023
1	Immunoglobulin G (IgG)IBA 01/2023
1	AntibodiesIBA 01/2023
1	Vaccine AdjuvantsIBA 05/2022
1	2,4-diaminoquinazolineIBA 05/2022
1	FurinIBA 01/2022
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	Oncostatin MIBA 01/2022
1	remdesivirIBA 02/2021
1	NucleotidesIBA 01/2021
1	Tripartite Motif ProteinsIBA 09/2020
1	UbiquitinIBA 09/2020
1	Ligases (Synthetase)IBA 09/2020
1	Nylidrin (Buphenine)FDA LinkGeneric 01/2020
1	Untranslated RNA (Noncoding RNA)IBA 06/2019
1	Adenine NucleotidesIBA 06/2019
1	Niclosamide FDA Link 01/2019
1	salinomycinIBA 12/2018
1	Nuclear Proteins (Protein, Nuclear)IBA 12/2018
1	Protons (Proton)IBA 12/2018
1	RibonucleoproteinsIBA 12/2018
1	Monovalent CationsIBA 12/2018
1	AntiportersIBA 12/2018
1	Therapeutic UsesIBA 12/2018
1	Small Molecule LibrariesIBA 12/2018
1	OligonucleotidesIBA 01/2018
1	saracatinibIBA 01/2018
1	Ellagic AcidIBA 03/2017
1	Oseltamivir (Tamiflu)FDA Link 03/2017
1	caffeic acidIBA 03/2017
1	Neuraminidase (Sialidase)IBA 03/2017
1	tetrapeptide carbamateIBA 03/2017
1	methyl gallateIBA 03/2017
1	NucleoproteinsIBA 10/2016
1	5,6- dimethyl- 3H,3'H- spiro(benzofuran- 2,1'- isobenzofuran)- 3,3'- dioneIBA 10/2016
1	Micafungin (FK463)FDA Link 06/2016
1	NucleosidesIBA 12/2015
1	Ribavirin (Virazole)FDA LinkGeneric 12/2015
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 08/2014
1	Organic Chemicals (Chemicals, Organic)IBA 07/2014
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 11/2013
1	Polysaccharides (Glycans)IBA 02/2012
1	RNA Polymerase II (RNA Polymerase B)IBA 08/2006
1	Circular DNAIBA 08/2006

Therapy/Procedure

6	Therapeutics 10/2020 - 06/2007
2	Immunotherapy 11/2018 - 01/2018
1	Intranasal Administration 12/2021